Valuation Metrics and Recent Changes
As of 30 Jul 2026, Cholamandalam Investment & Finance Company Ltd (stock code 972395) trades at ₹1,804.15, up 2.95% from the previous close of ₹1,752.50. The stock’s 52-week range spans from ₹1,299.80 to ₹1,874.65, indicating it is currently trading near its upper band. The company’s market capitalisation places it firmly in the large-cap category, reflecting its established presence in the Non Banking Financial Company (NBFC) sector.
However, the valuation grade has shifted from expensive to very expensive, driven primarily by its price-to-earnings (P/E) ratio of 26.75 and price-to-book value (P/BV) of 5.05. These figures suggest that the stock is trading at a premium relative to its book value and earnings, signalling heightened investor expectations. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 15.63, further underscoring the premium valuation.
Despite this, the company’s PEG ratio is 0.98, which is below the critical threshold of 1.0, indicating that the stock’s price growth is reasonably aligned with its earnings growth potential. This metric often appeals to growth-oriented investors seeking value in premium-priced stocks.
Peer Comparison Highlights
When compared with peers in the NBFC sector, Cholamandalam’s valuation appears competitive yet elevated. Bajaj Finance, a sector heavyweight, trades at a P/E of 34.15 and EV/EBITDA of 19.3, both higher than Cholamandalam’s metrics, and is also rated very expensive. Similarly, Shriram Finance’s P/E ratio of 21.72 and EV/EBITDA of 13.21 place it in the very expensive category as well.
On the other hand, Life Insurance companies such as Life Insurance Corporation and SBI Life Insurance present contrasting valuations. LIC trades at a very attractive P/E of 9.33 and EV/EBITDA of 10.02, while SBI Life Insurance’s P/E is significantly higher at 73.17, reflecting sector-specific valuation dynamics. Jio Financial and Tata Capital are also classified as expensive, with P/E ratios of 79.76 and 28.22 respectively.
This peer context suggests that while Cholamandalam is expensive, it remains more reasonably priced than some of the highest-valued NBFCs, offering a relative value proposition within the sector.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Performance and Returns Analysis
Cholamandalam’s return profile over various time horizons has been impressive, significantly outperforming the Sensex benchmark. Over the past one year, the stock has delivered a 21.60% return compared to the Sensex’s negative 4.53%. The three-year and five-year returns stand at 58.75% and 270.54% respectively, dwarfing the Sensex’s 17.37% and 47.48% returns over the same periods. The ten-year return is particularly striking at 726.08%, underscoring the company’s long-term growth trajectory.
These returns reflect the company’s ability to generate shareholder value consistently, supported by a return on equity (ROE) of 17.18% and a return on capital employed (ROCE) of 9.21%. While the ROCE is moderate, the ROE indicates efficient utilisation of equity capital, a key metric for investors assessing profitability.
Dividend yield remains modest at 0.11%, suggesting that the company prioritises reinvestment and growth over immediate shareholder payouts, a typical characteristic of growth-oriented NBFCs.
Valuation Implications and Investor Considerations
The shift to a very expensive valuation grade warrants a nuanced interpretation. On one hand, the premium multiples reflect strong investor confidence in Cholamandalam’s growth prospects and financial stability. On the other, elevated valuations increase the risk of price corrections if growth expectations are not met or if broader market conditions deteriorate.
Investors should weigh the company’s solid fundamentals, including its robust returns and consistent outperformance against the Sensex, against the premium price paid. The PEG ratio below 1.0 offers some comfort that earnings growth may justify the current valuation, but the relatively high P/BV ratio of 5.05 signals that the stock is priced well above its net asset value, which may limit upside in a market downturn.
Given the company’s large-cap status and upgraded Mojo Grade to Buy (from Hold as of 20 Jul 2026), it remains an attractive option for investors seeking exposure to the NBFC sector with a blend of growth and relative stability. However, the very expensive valuation grade suggests that new investors should consider entry points carefully, ideally during market dips or corrections.
Thinking about Cholamandalam Investment & Finance Company Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this large-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Market Momentum and Price Action
Cholamandalam’s recent price momentum has been positive, with a one-week return of 4.37% outperforming the Sensex’s 1.17%. The one-month return of 1.54% also slightly exceeds the Sensex’s 1.21%. Year-to-date, the stock has gained 5.99%, contrasting with the Sensex’s decline of 8.88%, highlighting the stock’s resilience amid broader market volatility.
Intraday trading on 30 Jul 2026 saw the stock reach a high of ₹1,836.45 and a low of ₹1,777.00, indicating healthy liquidity and investor interest. The proximity to its 52-week high of ₹1,874.65 suggests sustained buying interest, although the narrow range also points to some consolidation.
Investors should monitor upcoming earnings announcements and sector developments closely, as these will likely influence valuation multiples and price direction in the near term.
Conclusion: Balancing Valuation with Growth Potential
Cholamandalam Investment & Finance Company Ltd’s transition to a very expensive valuation grade reflects both its strong market position and the premium investors are willing to pay for its growth prospects. While the elevated P/E and P/BV ratios caution against complacency, the company’s robust returns, favourable PEG ratio, and large-cap status support a positive investment thesis.
For existing shareholders, the current valuation justifies holding the stock, given its consistent outperformance and upgraded Mojo Grade to Buy. Prospective investors should consider valuation risks and seek opportunities to enter at more attractive price points, balancing the company’s quality metrics against the premium valuation.
Overall, Cholamandalam remains a compelling NBFC large-cap stock with a strong track record, but its very expensive valuation necessitates careful portfolio positioning and ongoing monitoring of sector dynamics.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
